CAS: 105806-65-3 - Efegatran
Formula:C21H32N6O3
InChI:InChI=1/C21H32N6O3/c1-24-17(13-15-7-3-2-4-8-15)20(30)27-12-6-10-18(27)19(29)26-16(14-28)9-5-11-25-21(22)23/h2-4,7-8,14,16-18,24H,5-6,9-13H2,1H3,(H,26,29)(H4,22,23,25)/t16-,17+,18-/m0/s1
- Sinonimi:
- Efegatran [INN]
- Ly 294468
- Unii-Vt0Vk2474K
- L-Prolinamide, N-methyl-D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (S)-
- N-methyl-D-phenylalanyl-N-{(2S)-5-[(diaminomethylidene)amino]-1-oxopentan-2-yl}-L-prolinamide
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Efegatran REF: TM-T25364CAS: 105806-65-3 | - - - | 1.435,00 €~2.359,00 € | Mar 10 Dic 24 |
 | Efegatran REF: 3D-FE163232CAS: 105806-65-3 | Min. 95% | Prezzo su richiesta | Mar 10 Dic 24 |
Efegatran
CAS:105806-65-3
Efegatran is a hematologic agent and platelet aggregation inhibitor.
Formula:
C21H32N6O3
Colore e forma:
Solid
Peso molecolare:
416.52
Ref: TM-T25364
| 25mg | 1.435,00 € | ||
| 50mg | 1.869,00 € | ||
| 100mg | 2.359,00 € |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
Efegatran
CAS:105806-65-3
Efegatran is a chemical compound that has a number of clinical indications, including the treatment …
Formula:
C21H32N6O3
Purezza:
Min. 95%
Peso molecolare:
416.52 g/mol
Ref: 3D-FE163232
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
